Table 3

Parotid gland biopsy results

PedSjD
n=19
Diagnostic adSjD
n=32
PedSjD versus diagnostic adSjD
P value
Trial adSjD
n=42
PedSjD versus trial adSjD
P value
Focus score*2.6 (1.3–3.4)1.1 (0.3–1.8)†0.0031.82 (1.2–4.67)0.79
 Focus score ≥1, n (%)16 (84.2)21 (65.6)0.2036 (85.7)1.00
CD45+ cells* (% of parenchyma)20.4 (9.3–35)10.35 (2.26–24.01)0.04116.3 (4.9–28.9)0.46
LELs/mm2*0.00 (0.00–0.29)0.14 (0.00–0.26)0.940.08 (0.00–0.35)0.79
 Presence of LELs, n (%)9 (48)18 (56)0.5423 (56)0.53
 LEL severity (1–3)*2 (1–3)2 (1–3)0.871 (1–2)0.27
CD21+ FDC networks/mm2*0.21 (0.06–0.79)†0.00 (0.00–0.35)0.0290.21 (0.00–0.46)0.28
Bcl6+ ectopic GC/mm2*0.14 (0.04–0.33)0.00 (0.00–0.12)0.0020.00 (0.00–0.24)0.018
CD3+ cells/mm2*1384 (841–1883)470 (177–1406)0.029715 (256–1917)0.15
CD20+ cells/mm2*1679 (428–2811)376 (61–1003)0.004624 (108–1300)0.023
CD20/(CD20+CD3) ratio*0.51 (0.32–0.58)0.39 (0.25–0.48)0.0130.40 (0.23–0.50)0.023
CD3/CD20 segregation, n (%)14 (74)18 (56)0.2124 (57)0.22
IgA/IgG plasma cell shift, n (%)9 (47)18 (56)0.5424 (57)0.48
IgM+plasma cells/mm2*68 (25–156)42 (10–93)0.0929 (6–93)0.007
  • Significant p values are italicised and bold.

  • *Data are reported as median (IQR) or n (%).

  • †Missing data: 0–5.

  • adSjD, adult-onset Sjögren’s disease; FDC, follicular dendritic cell; GC, germinal centre; IgA, immunoglobulin A; LEL, lymphoepithelial lesion; PedSjD, paediatric-onset Sjögren’s disease.